Zinger Key Points
- The 299 participants, averaging 66.7 years old, showed that approximately 90% of patients used medical cannabis to treat chronic pain.
- The study also documented improvements in pain levels, sleep quality, and overall quality of life.
A new study conducted by a division of Tilray Brands, Inc. TLRY reveals that a substantial majority of medical marijuana patients over the age of 50 are utilizing cannabis to manage chronic pain and arthritis.
This research highlights the growing trend among older adults turning to cannabis as an effective treatment option for persistent health issues.
Findings from the Research
The Tilray Medical study, titled "Medical Cannabis for Patients Over Age 50: A Multi-Site, Prospective Study of Patterns of Use and Health Outcomes," focuses on the real-world effects of medical cannabis on patients over 50, monitored under healthcare supervision. This builds on previous research indicating that older patients represent a significant and growing subset of medical marijuana users. Among those seeking treatment, chronic pain (27.8%), arthritis (14.9%), and anxiety (9%) were the most common conditions.
Health Improvements and Patient Demographics
The study’s findings are noteworthy. The 299 participants, averaging 66.7 years old and 62.2% identifying as female, showed that approximately 90% of patients used medical cannabis for pain-related conditions such as chronic pain and arthritis. The study also documented improvements in pain levels, sleep quality, and overall quality of life, along with a reduction in the use of other medications.
José Tempero, Tilray’s medical director, emphasized the importance of this research: “Our involvement in this initiative demonstrates our commitment to advancing medical research and providing products that support comprehensive studies. This brings us closer to unlocking the full therapeutic potential of medical cannabis, particularly for an aging population.”
Implications and Upcoming Discussions
These findings come at a time for the cannabis industry, with ongoing research focusing on the benefits of medical marijuana. This topic will be part of broader discussions at Benzinga's Cannabis Capital Conference, scheduled for October 8-9, 2024, in Chicago. The conference will bring together big names in cannabis investment and branding, offering a platform for extensive networking and deal-making opportunities. This event will allow participants to explore the therapeutic potential of medical cannabis, including its use among older adults.
Now Read:
Photo: Courtesy of Maxim Apryatin via Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.